Switch to: References

Add citations

You must login to add citations.
  1. Ethics in occupational health: deliberations of an international workgroup addressing challenges in an African context.Leslie London, Godfrey Tangwa, Reginald Matchaba-Hove, Nhlanhla Mkhize, Remi Nwabueze, Aceme Nyika & Peter Westerholm - 2014 - BMC Medical Ethics 15 (1):1-11.
    BackgroundInternational codes of ethics play an important role in guiding professional practice in developing countries. In the occupational health setting, codes developed by international agencies have substantial import on protecting working populations from harm. This is particularly so under globalisation which has transformed processes of production in fundamental ways across the globe. As part of the process of revising the Ethical Code of the International Commission on Occupational Health, an Africa Working Group addressed key challenges for the relevance and cogency (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • Legal responses to placebo-controlled trials in developing countries.Ilja Richard Pavone - 2016 - Global Bioethics 27 (2-4):76-90.
    The conduct of clinical trials involving placebo in developing countries in the presence of an existing effective treatment triggered an intense debate on the standard of care to be provided to those populations. Charges of exploitation of vulnerable groups and double standards have been raised by several scholars. In response to these concerns, the Declaration of Helsinki was revised in 2000, 2008 and 2013, eventually endorsing the golden standard instead of the local standard of care. The European Union adopted a (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.Pamela Andanda & Jane Wathuta - 2018 - Medicine, Health Care and Philosophy 21 (1):139-155.
    This paper discusses the need to focus on the dignity of human participants as a legal and ethical basis for providing post-trial access to healthcare. Debate about post-trial benefits has mostly focused on access to products or interventions proven to be effective in clinical trials. However, such access may be modelled on a broad fair benefits framework that emphasises both collateral benefits and interventional products of research, instead of prescribed post-trial access alone. The wording of the current version of the (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations